Kidney transplantation in patients with tuberous sclerosis complex
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14765 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Amber M Goedken und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Kidney Transplantation, Waiting Lists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AHRQ HHS, NIGMS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Tuberous sclerosis complex (TSC) is a disorder of the mammalian target of the rapamycin (mTOR) pathway associated with the development of multisystem tumors, including renal angiomyolipoma (AML). These renal tumors are benign by nature but locally invasive and carry a risk for the progression of chronic kidney disease (CKD) to end stage kidney disease (ESKD). The frequency of subsequent renal transplantation in this population is largely uncharacterized, although single‐center data suggests that 5%–15% of adult TSC patients are kidney transplant recipients.
Methods
This retrospective cohort study utilized United Network for Organ Sharing (UNOS) data. We included candidates waitlisted between 1987 and 2020 for a first kidney transplant with TSC‐associated kidney failure. We utilized descriptive statistics to characterize the frequency of first‐time kidney transplant waitlisting and transplantation among persons with TSC and the Fine‐Gray subdistribution hazard model to evaluate characteristics associated with progression from waitlist.
Results
We identified 200 TSC‐associated kidney failure patients within the waitlist cohort. Of these, 12 were pediatric patients. Two‐thirds ( N = 134) of waitlisted persons were female. One hundred forty patients received a transplant with a median waitlist time of 2 years. Younger age at waitlisting was associated with a greater probability of progressing to transplant (HR 0.98 [95% CI: 0.96–0.99]). 91.8% of kidney transplant recipients survived 1‐year post‐transplant with a functioning allograft.
Conclusions
The majority of patients with TSC who are waitlisted for a kidney transplant progress onto transplantation with excellent 1‐year post transplant patient and allograft survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, Iowa City, Iowa, USA.
- Stead Family Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
- Medical Scientist Training Program, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
- Department of Epidemiology, University of Iowa College of Public Health, Iowa City, Iowa, USA.
ORCID-Profile: Amber M Goedken, Wesam W Ismail, Lucas D G Barrett, Lyndsay A Harshman
Förderung
- AHRQ HHS
- NIGMS NIH HHS
- NIDDK NIH HHS
- NIH HHS
- HRSA HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- Health Resources and Services Administration
- Agency for Healthcare Research and Quality
Zitieren
APA
Goedken, A. M., Ismail, W. W., Barrett, L. D. G., & Harshman, L. A. (2024). Kidney transplantation in patients with tuberous sclerosis complex. Pediatric Transplantation. https://doi.org/10.1111/petr.14765
Vancouver
Goedken AM, Ismail WW, Barrett LDG, Harshman LA. Kidney transplantation in patients with tuberous sclerosis complex. Pediatric Transplantation. 2024. doi:10.1111/petr.14765
BibTeX
@article{Goedken2024,
author = {Goedken, Amber M and Ismail, Wesam W and Barrett, Lucas D G and Harshman, Lyndsay A},
title = {Kidney transplantation in patients with tuberous sclerosis complex},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14765}
}
EUVIMED